Health Care Technology

GOODWILL

GOODWILL released FY2026 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 84.78 M, actual EPS CNY -0.1

GOODWILL FY2026 Q1 Earnings Release Scheduled for April 29 After-Market BJT

GOODWILL to Release FY2025 Earnings on April 29 Pre-Market (BJT), Forecast Revenue CNY 595.23 M, EPS CNY -0.475

GOODWILL released FY2025 Q4 earnings on February 27 Pre-Market (BJT), actual revenue CNY 77.81 M, actual EPS CNY -0.5813

GOODWILL released FY2025 annual earnings on February 27 Pre-Market (BJT), actual revenue CNY 407.67 M (forecast CNY 595.23 M), actual EPS CNY -1.84 (forecast CNY -0.475)

GOODWILL released FY2025 9-month earnings on October 29 After-Market BJT, actual revenue CNY 329.86 M, actual EPS CNY -1.2487

GOODWILL released FY2025 Q3 earnings on October 29 After-Market (BJT), actual revenue CNY 111.17 M, actual EPS CNY -0.4102

GOODWILL to Release FY2025 Q3 Earnings on October 30 After-Market (BJT)

GOODWILL released FY2025 Q2 earnings on August 27 After-Market (BJT), actual revenue CNY 117.49 M, actual EPS CNY -0.7085

GOODWILL released FY2025 Semi-Annual earnings on August 27 After-Market (BJT), actual revenue CNY 218.69 M, actual EPS CNY -0.85

GOODWILL to Release FY2025 Semi-Annual Earnings on August 29, 2025 (BJT)

Jiahemeikang's shareholder Guoshouchengda plans to reduce shareholding

National Life Chengda Reduced Holdings in Jiahe Meikang to 9.22%

Jiahe MeiKang Conducted A Block Trade

Jiahe Mei Kang's Shareholder Reduced Shares

National 寿成达 Reduces Holdings in Jihe MeiKang to 1%

GuoShou ChengDa Reduced Holdings in JiaHe MeiKang Exceeding 1% Threshold

Hongyunjiukang Plans to Reduce Holdings in Jiameikang No More Than 1%

Jiahe Meikang's Q1 2025 Revenue Down, Loss Widened

GOODWILL released FY2025 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 101.2 M, actual EPS CNY -0.13

301230

301333

000516

300404

688246

AI healthcare and AI pharmaceutical concepts are experiencing volatile adjustments, with PR falling over 18%, R&G Pharma down nearly 15%, and IMIC, BOJI CRO, GOODWILL, and Berry Genomics all dropping more than 5%

Wallstreetcn

R&G Pharma

IMIC

BOJI CRO

According to the Zhitong Finance APP, GOODWILL announced that on September 10, 2025, it received a "Notice of Shareholder Reduction Plan" issued by Sequoia Capital, stating that due to liquidity needs, shareholder Sequoia Capital plans to reduce its holdings of the company's shares by no more than 2.6725 million shares, which is no more than 1.94% of the company's total share capital, through centralized bidding based on market conditions. This will be conducted within 90 days after the announcement is disclosed, starting from the third trading day

Zhitong

GOODWILL: Saifu Puxin plans to reduce its holdings by no more than 1.94% of shares

According to the Zhitong Finance APP, GOODWILL announced that its shareholder Hongyun Jiukang Data Technology (Beijing) Co., Ltd. (referred to as "Hongyun Jiukang") plans to reduce its holdings of the company's shares by no more than 1.3759 million shares, or no more than 1% of the company's total share capital, through centralized bidding based on market conditions starting from October 9, 2025, within a period of three months

GOODWILL shareholder Hongyun Jiukang plans to reduce its holdings by no more than 1% of the shares

GOODWILL announced that the company will directly hold 58.7006% of the equity in GOODWILL Haishen. The natural person shareholders of the controlling subsidiary GOODWILL Haishen will transfer their shares to the company's related parties, and GOODWILL Information will waive its right of first refusal. After the transaction, the shareholding ratio remains unchanged, changing from indirect holding to direct holding. This transaction is a related party transaction and needs to be submitted for review at the fourth extraordinary shareholders' meeting in 2025. GOODWILL Haishen's net profit for the first half of 2025 was -19.9129 million yuan

GOODWILL: The company will directly hold 58.7006% of the equity in GOODWILL Haishen

GOODWILL announced that its operating revenue in the first half of 2025 was 219 million yuan, a year-on-year decrease of 27.22%. The net profit attributable to shareholders of the listed company was -116 million yuan, compared to -27.4722 million yuan in the same period last year

GOODWILL: Net loss of 116 million yuan in the first half of 2025

GOODWILL announced that its shareholder Hongyun Jiukang Data Technology Co., Ltd. has reduced its holdings of the company's shares by 1.3759 million shares through centralized bidding from June 9, 2025, to August 5, 2025, accounting for 1% of the total share capital, with a reduction price range of 30 to 38.43 yuan/share, totaling 45.6139 million yuan; after this reduction, it holds 8.4859 million shares, accounting for 6.17%, and the reduction plan has been completed

GOODWILL: Hongyun Jiukang 1% reduction completed

According to the Zhitong Finance APP, GOODWILL announced that its shareholder Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership) (referred to as "Guoshou Chengda") plans to reduce its holdings of the company's shares through centralized bidding and block trading, with a total reduction not exceeding 4.1276 million shares, which is no more than 3% of the company's total share capital

GOODWILL shareholder China Life Chengda plans to reduce its holdings by no more than 3%

GOODWILL announced that China Life Chengda Health Industry Equity Investment Center has completed the reduction of 4.1276 million shares, with its shareholding ratio decreasing from 12.22% to 9.22%. This reduction was carried out through centralized bidding and block trading, with a reduction price ranging from 23.05 to 30.25 yuan/share, totaling 105 million yuan

GOODWILL: China Life Chengda reduced its holdings by 4.1276 million shares

According to the Zhitong Finance APP, GOODWILL announced that the company recently received a notice from its shareholder, Sequoia Capital, regarding the results of the share reduction. From April 3, 2025, to June 27, 2025, a total of 2.0638 million shares were reduced through centralized bidding, accounting for 1.5% of the company's current total shares. This share reduction plan has been completed

GOODWILL: Sequoia Capital has cumulatively reduced its holdings in the company by 1.5%

601600

02600

000503

On June 13th, a total of 7 listed companies had their restricted shares unlocked, with a total market value of approximately 1.534 billion yuan. The specific situation of the restricted shares unlocking today is as follows: Stock Abbreviation Stock Code Restricted Share Type Unlocked Shares GuoXin Health 000503 Additional Issuance A Shares Legal Person Allocation Listed 24.124 million CHALCO 601600 Equity Incentive Restricted Circulation 32.8082 million Sanxiang New Materials 603663 Equity Incentive Restricted Circulation 560,000 Ligong Optical Science 300557 Equity Incentive Restricted Circulation 103,300 Rongtai Co., Ltd. 605133 Equity Incentive Restricted Circulation 416,600 Hongbai New Materials 605366 Equity Incentive Restricted Circulation 2.6426 million GOODWILL 688246 3,663,600

GOODWILL(688246.SH)